Press Releases-From Half-Life to Full-Life.

Jan 17, 2023

Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer

Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO).

Nov 29, 2022

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Acquisition accelerates Full-Life’s transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform

Aug 10, 2022

Full-Life Technologies Deepens Radioisotope Technology Expertise with Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board

Shanghai, China & Brussels, Belgium - August 10, 2022 - Full-Life Technologies Co., Ltd. (“Full-Life”) today announced two key appointments to its Radioisotope Technology leadership team and the establishment of a Radioisotope Technology Advisory Boar

May 26, 2022

Full-Life Technologies Completes $37 Million (USD)Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform

Full-Life Technologies (“Full-Life”) today announced it completed a $37 million (USD) Series A financing round to advance the development of its radiopharmaceutical oncology product pipeline and its radiotechnology production platform.

Jan 04, 2022

Full-Life Technologies Announces Senior Executive Team Appointments

Ravi Chari, Ph.D., appointed Chief Scientific Officer Julie Wu appointed Chief Financial Officer, Philippe van Put appointed General Manager, Europe Lanny Sun appointed Chairman.